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Edited by Jesus AvilaAbstract Microtubule plus-end proteins CLIP-170 and EB1
dynamically track the tips of growing microtubules in vivo. Here
we examine the association of these proteins with microtubules
in vitro. CLIP-170 binds tubulin dimers and co-assembles into
growing microtubules. EB1 binds tubulin dimers more weakly,
so no co-assembly is observed. However, EB1 binds to CLIP-
170, and forms a co-complex with CLIP-170 and tubulin that
is recruited to growing microtubule plus ends. The interaction
between CLIP-170 and EB1 is competitively inhibited by the
related CAP-Gly protein p150Glued, which also localizes to
microtubule plus ends in vivo. Based on these observations, we
propose a model in which the formation of distinct plus-end com-
plexes may diﬀerentially aﬀect microtubule dynamics in vivo.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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p150Glued1. Introduction
Live cell imaging has revealed a group of proteins that spe-
ciﬁcally and dynamically track the tips of growing microtu-
bules. These plus-end proteins are evolutionarily conserved
and may regulate microtubule dynamics and microtubule-
based transport (reviewed in [1]). While the in vivo behavior
of these proteins has been examined, the mechanisms driving
their plus-end localization remain unclear. Here we have exam-
ined the mechanisms of plus-end tracking for the proteins
CLIP-170 and EB1.
CLIP-170 was originally identiﬁed as a linker between endo-
somes and microtubules [2] and EB1 was identiﬁed as a binding
partner for the adenomatous polyposis coli protein (APC) [3].
GFP fusion proteins of each revealed that they track the
plus-ends of growing microtubules in cells [4,5]. At the amino
terminus of CLIP-170 are two tandem CAP-Gly microtubule
binding domains [6]. A similar domain is found in the p150Glued
subunit of the cytoplasmic dynein activator complex dynactin,
which also shows plus-end localization in some cell types [7].
EB1 is part of a family of proteins that includes EB3 and
RP1 [8]; these proteins share a microtubule-binding domain
that is structurally distinct from the CAP-Gly domain [9,10].
Proteins can show dynamic localization to microtubule plus-
ends either through an association with a plus-end directed*Corresponding author. Fax: +1 215 573 5851.
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doi:10.1016/j.febslet.2006.01.050motor protein or by treadmilling on the microtubule end.While
some proteins are actively transported to microtubule plus ends
by kinesins [11], analysis of the dynamics of GFP fusion pro-
teins has suggested that CLIP-170 and EB1 treadmill on the
tips of growing microtubules by adding on at the plus-end
and releasing just proximal to the end [4,12]. Several mecha-
nisms could account for this treadmilling behavior. The end
of a growing microtubule is biochemically and structurally dis-
tinct from that of a shrinking microtubule [13,14], and plus-end
proteins may have a higher aﬃnity for growing ends than for
either shrinking ends or the microtubule lattice. Alternately, a
plus-end protein could bind to tubulin dimers in the cytoplasm
and co-polymerize with them, as suggested by Diamantopoulos
et al. [15]. Here we have examined the plus end-targeting of
CLIP-170 and EB1 in vitro, and provide evidence for distinct
mechanisms for the plus end localization of these proteins.2. Materials and methods
2.1. Generation of recombinant proteins
Recombinant constructs of CLIP-170 (an in-frame T7 tag was fused
to the N-terminus of the previously characterized H2 construct [16]
generously provided by Holly Goodson, Notre Dame University)
and p150Glued (residues 1–333) [17], which span the microtubule
binding domains of these proteins, as well as full length EB1 [17], were
expressed as His-tagged fusion proteins in E. coli and puriﬁed by Ni2+-
chromatography.
2.2. Microtubule decoration assays
Stable microtubules were polymerized from 15 lM tubulin dimers
(Cytoskeleton, Denver, CO) in the presence of 1 mM GTP and
200 lM taxol, then centrifuged at 39000 · g and resuspended in warm
PEM-50 buﬀer (100 mM PIPES, 1 mM EDTA, 1 mM MgCl2, pH 7.3)
with 50 mM NaCl, 1 mM MgGTP, and 20 lM taxol. For assembly
assays these microtubules were sheared to generate seeds [17]. For
polarity marked microtubules, rhodamine-conjugated tubulin (Cyto-
skeleton) was polymerized at a 1:20 ratio to unlabeled tubulin to form
brightly labeled seeds, followed by polymerization in 15 lM tubulin at
a ratio of 1:50 rhodamine-labeled to unlabeled tubulin dimers to gen-
erate more dimly labeled polymer.
For tip-localization experiments, microtubules were polymerized
from 15 lM tubulin dimers and taxol-stabilized microtubules seeds
in PEM-50 buﬀer, then plus-end proteins were added to ﬁnal concen-
trations of 0.3, 3.0, or 9.0 lM monomer, as noted, and incubated two
minutes at 37 C. For co-assembly experiments, plus-end proteins were
pre-incubated with 15 lM tubulin dimers on ice for 5 min, mixed with
microtubule seeds and 1 mMGTP to initiate polymerization, and incu-
bated for 2 min at 37 C prior to ﬁxation.
Microtubules were ﬁxed with gluteraldehyde and pelleted onto cov-
erslips as previously described [17], then labeled with primary antibod-
ies to tubulin (Sigma, St. Louis, MO; Cytoskeleton), EB1 (BD
Transduction Laboratories, San Jose, CA), T7 (Novagen, Madison,
WI; Covance, Berkeley, CA), p150Glued (UP235 generated in ourblished by Elsevier B.V. All rights reserved.
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Micrographs were acquired with consistent exposure times between
comparable images; only linear image enhancement algorithms were
applied. Fluorescence intensity linescans were performed on randomly
selected microtubules with both ends visible in the frame using ImageJ
(Rasband, W.S., ImageJ, NIH, Bethesda, MD). Pixel values along the
microtubule were measured and the ratio of measured intensity values
to the mean intensity value was calculated. To analyze distributions,
microtubules were divided into three equal segments (end 1, middle
and end 2) and the area under the curve of the ﬂuorescence intensity
plot was calculated for each segment.
2.3. Binding assays
For microtubule binding assays, puriﬁed recombinant CLIP-170-H2
or EB1 at 3 lM (expressed as monomer concentration throughout)
was incubated with increasing concentrations of microtubules for
30 min at 37 C in PEM-50 buﬀer with 1 mMMgGTP and 20 lM tax-
ol. After centrifugation (39000 · g), supernatant and pellet fractions
were analyzed by SDS–PAGE and ImageJ. The data were analyzed
as saturation binding with ligand depletion [18], based on a 1:1 binding
stoichiometry of tubulin dimers to CLIP-170 monomer and ﬁt to the
one site binding equation [y = (Bmax*x)/(Kd + x)], where x is the free
ligand concentration, y is the fraction bound, Bmax is the maximal
binding, and Kd is the concentration for half-maximal binding by non-
linear regression using Prism software (GraphPad, San Diego, CA).
For comparison, binding data were also analyzed based upon a 2:1
binding stoichiometry and ﬁt to either a one or two site model. The
two site equation [y = (Bmax1*x)/(Kd1 + x) + (Bmax2*x)/(Kd2 + x)] rep-
resents a minimal model that assumes the two sites are independent,
whereas the tandem sites in CLIP-170 are linked and therefore the ac-
tual ﬁt is likely to be more complex. All binding studies were per-
formed in triplicate.
For tubulin binding assays, puriﬁed recombinant H2 and EB1 were
covalently linked to CH-Sepharose 4B beads at an initial concentration
of 2–5 mg protein/ml beads [17]. Ten microliter aliquots of beads were
incubated for 90 min at 4 C with increasing concentrations of tubulin
in PEM buﬀer with 0.1 mMMgGTP. Tubulin dimers were centrifuged
at 350000 · g for 10 min at 4 C immediately prior to incubation to re-
move oligomers and aggregates. Bound versus free fractions were sep-
arated by either low speed centrifugation or ﬁltration through a PALL
NanoSep device (300 K cutoﬀ) and analyzed by SDS–PAGE and den-
sitometry using ImageJ; after subtracting background binding to
blocked control beads, the percent maximal binding was plotted as a
function of tubulin concentration and ﬁt to the one site binding equa-
tion [y = (Bmax*x)/(Kd + x)] by nonlinear regression using Prism soft-
ware. All binding experiments were performed in triplicate.
2.4. Column chromatography
Puriﬁed tubulin, BSA, or the H2 fragment of CLIP-170 was cova-
lently linked to CH Sepharose 4B beads [17]. Recombinant EB1 and
p150Glued (1–333) at 5 lM each were incubated either singly or to-
gether with tubulin-bound, CLIP-170-bound or BSA-bound beads,
as noted, for 1 h in 50 mM Tris, 50 mM KCl, with 0.1% Triton X-
100. The beads were washed and eluted with 2 M NaCl.3. Results
3.1. Plus-end proteins do not preferentially bind to microtubule
ends in vitro
To understand the mechanisms of microtubule plus-end
speciﬁcity, we sought to reconstitute plus-end binding
in vitro with proteins that track the ends of growing microtu-
bules in vivo. We added full-length recombinant EB1 or a well-
characterized recombinant fragment of CLIP-170 (H2) [16]
that includes the N-terminal tandem CAP-Gly microtubule-
binding domains (Fig. 1A) to microtubules polymerized
in vitro. To test whether these proteins show a higher aﬃnity
for the newly polymerized end of the microtubule than for
the microtubule lattice, we polymerized microtubules from
puriﬁed tubulin and taxol-stabilized seeds in taxol-free buﬀer,added the recombinant proteins either prior to or immediately
following a burst of polymerization; samples were then ﬁxed
after a 2 min incubation. Both CLIP-170 and EB1 bound
along the length of the microtubule with no enhancement at
the ends, as shown by representative micrographs and ﬂuores-
cent linescans (Fig. 1B and C).
Preferential plus-end localization was not dependent upon
the concentration of the plus-end protein. Experiments were
performed with 0.3, 3 and 9 lM recombinant proteins; at low-
er concentrations, less CLIP-170 or EB1 bound to the micro-
tubules, but the bound protein was distributed along the
length of the microtubule (Fig. 1B and data not shown).
3.2. CLIP-170 binds to tubulin dimers and co-polymerizes
in vitro
While neither CLIP-170 nor EB1 was speciﬁc for newly
formed microtubule ends, chemical crosslinking experiments
have shown that a CLIP-170 N-terminal fragment binds to
tubulin dimers, and therefore it has been proposed that
CLIP-170 may co-assemble with tubulin at the plus-end [15].
We compared the relative aﬃnity of CLIP-170 and EB1 for
microtubules and tubulin. Using microtubule co-sedimenta-
tion assays, we measured the aﬃnity of the H2 fragment
of CLIP-170 for microtubules, and estimated a Kd = 1.3 ±
0.3 lM (Fig. 2A) based upon a 1:1 stoichiometry of tubulin di-
mer to CLIP-170 H2 polypeptide. Alternatively, Scheel et al.
[16] have suggested that there is a 2:1 binding stoichiometry
of tubulin dimers to CLIP-170-H2 polypeptide due to the pres-
ence of two tandem CAP-Gly domains. Fitting our data to a
simple two site model, as shown in the inset to Fig. 2A, yields
approximate Kds of 0.02 and 7.5 lM.
By incubating increasing concentrations of GTP-tubulin
with a constant level of the H2 fragment of CLIP-170 cova-
lently bound to Sepharose beads, we measured an approximate
Kd of 0.6 ± 0.1 lM for the binding of CLIP-170 to unpolymer-
ized tubulin, assuming a 1:1 stoichiometry of tubulin dimer to
CLIP-170 (Fig. 2B). In contrast, the data for CLIP-170-tubu-
lin binding cannot be ﬁt to a two-site binding curve, suggesting
that CLIP-170 binds to unpolymerized tubulin dimers with a
1:1 stoichiometry. Under our experimental conditions, EB1
bound weakly to both microtubules and tubulin dimers (see
Fig. 3B below, and data not shown).
As CLIP-170 binds directly to tubulin, co-polymerization
may explain the robust plus-end speciﬁcity observed in vivo
[15]. To test this, CLIP-170-H2 (3.0 lM) was pre-incubated
with GTP-tubulin (15 lM) and then mixed with microtubule
seeds and shifted to 37 C to allow a brief pulse of new poly-
merization. Under these conditions, CLIP-170-H2 is recruited
to new polymer at the ends of microtubules (Fig. 2C); 66%
of the microtubules scored (n = 66) had concentrated CLIP-
170-H2 labeling at one end. In contrast, only 6% of the
microtubules scored (n = 35) showed a concentration of
CLIP-170-H2 labeling at one end if CLIP-170-H2 was not ﬁrst
pre-incubated with tubulin (as in Fig. 1B). We conﬁrmed that
the more heavily labeled end was the plus-end using polarity
marked microtubules (Fig. 2D). Together these data suggest
that CLIP-170 can bind to tubulin dimers and co-assemble
with them into microtubules, resulting in the concentration
of CLIP-170 at plus-ends, which are the site of most new
microtubule polymerization. In contrast, preincubation of
EB1 with tubulin did not result in the preferential localization
of EB1 to the growing microtubule plus end (data not shown).
Fig. 1. Neither CLIP-170 nor EB1 preferentially localizes to newly polymerized microtubule plus ends in vitro. (A) Schematic representations of the
proteins CLIP-170, p150Glued and EB1, which show plus end speciﬁcity in vivo, and the constructs used in this study. The CLIP-170-H2 fragment
used here contains the two N-terminal CAP-Gly microtubule-binding domains and part of the coiled-coil domain and the p150 (1–333) fragment
includes the N-terminal CAP-Gly microtubule-binding domain; full-length EB1 was used. (B) CLIP-170 (red) added to microtubules polymerized
in vitro is not concentrated at microtubule ends, but rather labels the entire microtubule length (green). No end speciﬁcity was observed over a range
of CLIP-170 concentrations including 3.0 lM (upper row) and (0.3 lM lower row). End to end ﬂuorescence intensity linescans were performed on
isolated microtubules to show the distribution of CLIP-170 labeling relative to tubulin labeling; no speciﬁcity for microtubule ends was observed.
Scale = 5 lm. (C) Recombinant EB1 (red) also did not localize speciﬁcally to newly polymerized microtubule ends (green) in either micrographs or
linescans. Scale = 5 lm.
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microtubule plus-ends
As CLIP-170 and EB1 co-localize to dynamic microtubule
plus ends in the cell, we tested whether these two proteins
may interact directly, similar to our previous observation that
EB1 binds to the related N-terminal CAP-Gly domain of
p150Glued [17]. We found that recombinant EB1 was speciﬁcally
retained on a CLIP-170-H2 column but not on a BSA control
column (Fig. 3A). In the reciprocal experiment, CLIP-170
bound speciﬁcally to an EB1-aﬃnity column (data not shown).
We then tested if CLIP-170 could recruit EB1 to tubulin. By
itself, EB1 does not bind strongly to tubulin dimers bound to an
aﬃnity matrix (Fig. 3B, left panel), but when EB1 was applied
to the tubulin column following preincubation with CLIP-170both proteins bound speciﬁcally (Fig. 3B, right panel), suggest-
ing that CLIP-170 can recruit EB1 to tubulin dimers.
We then tested whether CLIP-170 could recruit EB1 to
microtubule plus-ends in vitro. EB1 and CLIP-170-H2 (each
at 3 lM) were pre-incubated together with GTP-tubulin
(15 lM), added to microtubules and allowed to polymerize
brieﬂy. Under these conditions, both EB1 and CLIP-170-H2
show localization to the ends of microtubules (Fig. 3C). EB1
labeling was concentrated at one end of the microtubule in
55% of the microtubules scored (n = 36) when EB1 and
CLIP-170 were pre-incubated with tubulin. In contrast, EB1
labeling was concentrated at one end in only 4.5% of microtu-
bules scored (n = 44) when EB1 and CLIP-170 were added
without pre-incubation. Together these data suggest that
Fig. 2. CLIP-170 binds to and co-polymerizes with tubulin, resulting in localization to growing microtubule plus ends. (A) CLIP-170 bound to
microtubules with a Kd of 1.3 ± 0.3 lM, assuming a 1:1 binding stoichiometry and a ﬁt to a one site binding equation (see Section 2); data from three
independent experiments are shown (circles, squares, triangles). The inset shows the average data plotted assuming a binding stoichiometry of two
tubulin dimers to each CLIP-170 polypeptide, with ﬁts to either a one site (red line) or two site (blue line) binding model. (B) GTP-tubulin bound to
CLIP-170-beads with a Kd = 0.6 ± 0.1 lM. Error bars represent the standard error in the averages from three independent experiments. (C) CLIP-
170-H2 preincubated with tubulin dimers was added to microtubules. After a pulse of polymerization, CLIP-170 labeling (red) is concentrated at the
end of the microtubule (green). Scale = 5 lm. (D) CLIP-170 (green) (3 lM) preincubated with tubulin dimers (15 lM) labeled with a low
concentration of rhodamine tubulin (1:50), was added to microtubule seeds (polymerized with 1:20 rhodamine tubulin for bright seeds) and allowed
to polymerize, resulting in brighter rhodamine-tubulin labeling at the slow growing minus end in contrast to the brighter CLIP-170 labeling at the
more rapidly growing microtubule plus end. Scale = 5 lm.
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tubulin dimers and this complex can copolymerize with grow-
ing microtubules.3.4. CLIP-170 competes with p150Glued for binding to EB1
As both CLIP-170 and p150Glued bind to EB1 via their
N-terminal CAP-Gly microtubule-binding domains, we tested
Fig. 3. CLIP-170 binds to EB1, and recruits EB1 to growing
microtubule plus ends. (A) Recombinant EB1 bound to a CLIP-170-
H2 aﬃnity matrix, but not to a control BSA matrix (L, load; F, ﬂow-
through; W, wash; E, eluate). (B) CLIP-170 (middle panel) but not
EB1 (left panel) bound to a tubulin-aﬃnity matrix. Preincubation of
EB1 with CLIP-170 resulted in the binding of the co-complex to the
tubulin column (right panel; L, load; F, ﬂow-through; W, wash; E,
eluate). (C) CLIP-170 (3 lM) and EB1 (3 lM) preincubated with
tubulin dimers (15 lM) are recruited to growing microtubule ends, as
shown by both micrographs (CLIP-170, green; EB1, red; tubulin, blue;
























Fig. 4. Plus end proteins may form distinct complexes at the ends of
growing microtubules. (A) EB1 binds strongly to a CLIP-170-H2
aﬃnity matrix (left panel), but preincubation of EB1 with p150Glued
signiﬁcantly reduced the observed binding (middle panel). p150Glued
[1–333] does not bind to the CLIP-170 aﬃnity matrix (right panel). The
protein loaded and aﬃnity matrix are as noted; L, load; F, ﬂow-
through; W, wash; E, eluate. (B) Schematic illustrating a model for the
interactions among microtubule plus end proteins. The C-terminal
domain of CLIP-170 can bind to the N-terminal portion of the protein
and hold it in an auto-inhibited conﬁrmation. The C-terminus of
CLIP-170 can also bind to the N-terminal domain of p150Glued and
may inhibit its binding to microtubules as well. EB1 can bind to the N-
terminal domains of both CLIP-170 and p150Glued and may displace
the C-terminal inhibitory domain of CLIP-170, thereby opening up the
molecules. The open CLIP-170 or p150Glued in complex with EB1 can
then bind to tubulin and co-polymerize into microtubules.
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ciﬁcally retained on a CLIP-170-H2 column, but when EB1
and p150Glued are preincubated, the binding of EB1 to
CLIP-170 is reduced, suggesting that p150Glued is competing
for EB1 binding with CLIP-170 (Fig. 4A). This inhibition is
not the result of p150Glued itself binding to CLIP-170, as this
construct was not retained on the H2 column. Together these
data suggest that EB1 can bind to either p150Glued or CLIP-
170, resulting in distinct plus-end complexes, which may have
diﬀerential functions.4. Discussion
In the cell, plus-end proteins dynamically localize to the
growing ends of microtubules, but the mechanisms driving this
localization are not well understood. Here we have reconsti-
tuted microtubule plus-end localization of CLIP-170 and
EB1 in vitro. CLIP-170 binds to tubulin and co-polymerizes
into growing microtubules, as previously proposed [15], result-
ing in preferential localization to the faster-growing plus end.
In contrast, we have shown that in vitro, EB1 alone does not
1332 L.A. Ligon et al. / FEBS Letters 580 (2006) 1327–1332preferentially localize to microtubule plus ends. This observa-
tion is somewhat surprising, given the robust localization of
EB1 to growing microtubule plus ends in vivo [5], but is con-
sistent with our observations of relatively weak binding of
EB1 to either tubulin or microtubules. EB1 has been shown
to interact with multiple proteins in the cell, and the formation
of a co-complex may be required to accurately target the pro-
tein in vivo.
Consistent with this hypothesis, we have shown here that
EB1 binds directly to the CAP-Gly domain of CLIP-170, in
parallel to the binding of EB1 to the CAP-Gly domain of
p150Glued shown previously [17,19]. The EB1-CLIP-170 co-
complex binds to tubulin dimers, and can be eﬀectively re-
cruited to the ends of growing microtubules in vitro.
A co-complex of EB1 and p150Glued may also speciﬁcally
target microtubule plus ends in the cell; we have found in
HeLa cells that the depletion of p150Glued by RNAi leads to
a mislocalization of EB1 so that it is no longer as speciﬁc for
microtubule plus ends (Levy et al., manuscript submitted).
Overexpression of EB1 also leads to mislocalization along
the length of the microtubule [17]. Finally, we have shown that
CLIP-170 and p150Glued compete for binding to EB1, suggest-
ing that there may be distinct plus-end complexes that diﬀer
functionally, thus providing mechanisms to speciﬁcally and
sensitively regulate microtubule dynamics in the cell.
The binding of EB1 to the N-terminal domain of CLIP-170
may provide a mechanism for the co-regulation of the activity
of plus-end proteins. It has recently been demonstrated that
CLIP-170 folds to form an auto-inhibited conformation in
which the C-terminal binds to and blocks the activity of the
N-terminal portion of the protein [20]. These data suggest a
model, illustrated by the schematic in Fig. 4B, in which EB1
binds to the N-terminal domains of CLIP-170, displacing the
C-terminal inhibitory domain of CLIP-170 and opening up
the molecule. The open CLIP-170 in complex with EB1 can
then bind to tubulin and co-polymerize into microtubules.
Structural studies have also suggested that the binding of
EB1 to the CAP-Gly domain of p150Glued may activate this
complex for microtubule binding [21].
Together these data suggest that plus-end proteins may uti-
lize multiple mechanisms to localize to microtubule tips. There
may also be redundant mechanisms in vivo, as EB1 may be
localized via both CLIP-170-dependent and independent
mechanisms [22]. One of the clearest functions of plus-end pro-
teins is the regulation of microtubule dynamics. Both EB1 and
CLIP-170 have been shown to aﬀect the parameters of dy-
namic instability in cells and cell extracts. CLIP-170 promotes
rescue events (change from shortening to growing states) and
EB1 promotes rescues and decreases catastrophes (change
from growing to shortening states) [12,22]. If EB1 and CLIP-
170 co-polymerize with tubulin, then they are perfectly poised
to aﬀect the transitions between growth and shortening states.
Further, both the cooperative and competitive interactions
among these proteins that we have observed in vitro may func-
tion in vivo to provide microtubules with diﬀerential dynamics
and/or targeting signals localized speciﬁcally to their plus ends.
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